Ann: Orthocell Appoints Non-Executive Director Dr Ravi Thadhani, page-44

Speckled, over the course of fourteen months, I have sold my holdings down to 300 thousand, eight years I have bought into the dream of a mid to larger biotech company, hoping one day our share price will come good with 1000% profits.

Back in the day when we use to say, just wait until approvals, just wait until partnership, just wait until institutional investment buy in, guess what, no one really cares, investors are just not interested

I remember when we had a good announcement 20-50% gains, 800 trades for that day, I was profiting 120 thousand for that announcement, these days we get 2-10% profits for twenty minutes before it’s sold back down.

PA is on some big money 700 plus per year, when was the last time he bought shares at market price to support his company, to support the share price, the whole management team have let down every share holder over the years, this mop is so secretive about the latest partnership with BH it wouldn’t surprise me if Striate+ is sold off after a couple of years.

J&J have had close to 6 years to get into partnership with ATI, two years ago I asked management about getting ATI partnered, they said they were in discussions with a few BP, two years ago and here we are, I’m sorry but I can’t keep believing the bullshit management are throwing to there share holders anymore.

What ever happened to the money, where management were building a commercial facility in the states with 3.2 million dollars was set aside for this project, the numbers have never added up with this company

I hope I see a return on my holdings in the next few months, but I’m not holding my breath.